1. cbdMD regained NYSE American compliance, removing noncompliance indicator. 2. CEO highlights capital raise and share conversion as key to compliance. 3. The company emphasizes commitment to long-term shareholder value. 4. Ongoing compliance monitoring will continue from NYSE American. 5. Future performance remains subject to various risks and uncertainties.
FAQ
Why Bullish?
Regaining compliance with the NYSE can positively affect investor confidence and stock stability. Historical compliance reinstatement has generally led to positive stock price movements.
How important is it?
The compliance news is crucial for investor confidence, potentially enhancing YCBD's market perception. Maintaining compliance ties into broader financial health, impacting stock valuation.
Why Short Term?
The immediate effects of regaining compliance may boost stock price; however, long-term stability remains dependent on continued performance.
cbdMD, Inc. Regains Compliance with NYSE American Listing Standards
cbdMD, Inc. (NYSE American: YCBD), a recognized leader in wellness and hemp-derived products, has successfully regained full compliance with the NYSE American listing standards. This significant milestone has led to the removal of the ".BC" indicator, which designated the company as noncompliant, effective from the start of trading on December 8, 2025.
Achievement of Compliance
The NYSE American officially communicated this positive development to cbdMD in a letter dated December 5, 2025. The notification confirmed that the company has addressed all deficiencies related to Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.
CEO Comments on the Compliance Achievement
Ronan Kennedy, CEO of cbdMD, expressed his enthusiasm regarding this development: "We are excited to share this important news with our shareholders, partners, and team. Preserving our NYSE American listing was a critical achievement and reflects the tremendous work completed this year to strengthen our balance sheet and position the Company for sustainable growth."
Kennedy highlighted the pivotal steps the company undertook to achieve compliance, stating: "We believe our successful Series A Preferred share conversion in May and capital raise completed in September were essential components of our compliance strategy." He also acknowledged the valuable support from investors and stakeholders committed to cbdMD's long-term vision.
Future Commitments
As cbdMD moves forward, the company will continue to be subject to the NYSE American's ongoing listing monitoring procedures. The commitment to maintaining financial discipline and governance remains a priority as cbdMD seeks to enhance shareholder value.
Further Information
For additional details regarding this compliance achievement, shareholders and interested parties are encouraged to refer to the Company's Form 8-K, which will be filed with the Securities and Exchange Commission on December 8, 2025.
About cbdMD, Inc.
cbdMD, Inc. is among the most trusted and recognized brands in the cannabidiol (CBD) sector, offering a comprehensive range of U.S.-produced CBD products, as well as Farm Act compliant Delta 9 products. The company's product line includes:
- Paw CBD brand featuring veterinarian-formulated pet products
- Herbal Oasis THC Seltzer brand
- ATRx brand of natural functional mushroom support
To explore cbdMD’s extensive line of U.S. grown hemp products and learn more about its various brands, please visit www.cbdmd.com, www.pawcbd.com, www.herbaloasis.com, or ATRxlabs.com. You can also follow cbdMD on Instagram and Facebook or find their products at numerous retail locations.
Forward-Looking Statements
This announcement includes forward-looking statements as defined by U.S. federal securities laws. These statements reflect management's current expectations and assumptions regarding future performance and events. Various risks and uncertainties may affect actual results, including compliance with NYSE American continued listing requirements and factors disclosed in the Company’s filings with the U.S. Securities and Exchange Commission.
Contact Information
For media inquiries, please contact:
Ronan Kennedy
Chief Executive Officer and Chief Financial Officer
Email: [email protected]
Phone: (704) 445-3064